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Abstract
Imprinted genes play important roles in placental differentiation, growth and function, with profound effects on fetal
development. In humans, H19 and IGF2 are imprinted, but imprinting of IGF2R remains controversial. The H19 non-coding
RNA is a negative regulator of placental growth and altered placental imprinting of H19-IGF2 has been associated with
pregnancy complications such as preeclampsia, which have been attributed to abnormal first trimester placentation. This
suggests that changes in imprinting during the first trimester may precede aberrant placental morphogenesis. To better
understand imprinting in the human placenta during early gestation, we quantified allele-specific expression for H19, IGF2
and IGF2R in first trimester (6–12 weeks gestation) and term placentae (37–42 weeks gestation) using pyrosequencing.
Expression of IGF2R was biallelic, with a mean expression ratio of 49:51 (SD= 0.07), making transient imprinting unlikely.
Expression from the repressed H19 alleles ranged from 1–25% and was higher (P,0.001) in first trimester (13.568.2%)
compared to term (3.462.1%) placentae. Surprisingly, despite the known co-regulation of H19 and IGF2, little variation in
expression of the repressed IGF2 alleles was observed (2.762.0%). To identify regulatory regions that may be responsible for
variation in H19 allelic expression, we quantified DNA methylation in the H19-IGF2 imprinting control region and H19
transcription start site (TSS). Unexpectedly, we found positive correlations (P,0.01) between DNA methylation levels and
expression of the repressed H19 allele at 5 CpG’s 2000 bp upstream of the H19 TSS. Additionally, DNA methylation was
significantly higher (P,0.05) in first trimester compared with term placentae at 5 CpG’s 39–523 bp upstream of the TSS, but
was not correlated with H19 repressed allele expression. Our data suggest that variation in H19 imprinting may contribute to
early programming of placental phenotype and illustrate the need for quantitative and robust methodologies to further
elucidate the role of imprinted genes in normal and pathological placental development.
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Introduction
Genomic imprinting refers to parent-of-origin-dependent allele-
specific gene expression. Imprinting affects gene dosage, with the
imprinted allele considered repressed and functionally silenced
[1,2]. Imprinting is largely, although not exclusively, observed in
eutherian mammals and is thought to have arisen with viviparity
and the evolutionary emergence of the chorioallantoic placenta
[3,4]. The prevailing hypothesis on the origin of imprinting is
based on paternal-maternal conflict and postulates that paternally
expressed genes have been selected to maximize fetal resource
acquisition from the mother, while maternally expressed genes
have been selected to balance resource allocation to current and
future offspring [4]. As imprinted genes appear to facilitate this tug-
of-war between the maternal and paternal genomes, the conflict
hypothesis predicts that imprinted genes are involved in fetal and
placental growth and development during pregnancy [2,4,5].
Studies using animal models have demonstrated the functional
importance of imprinting of H19, IGF2 and IGF2R genes during
intrauterine development [6,7,8,9,10]. Paternally expressed IGF2
encodes the growth promoting insulin-like growth factor II, a
potent mitogen involved in regulating cell proliferation, growth
and development. The reciprocally imprinted, maternally ex-
pressed H19 gene is located approximately 130 kb downstream of
IGF2 on human chromosome 11 and encodes a highly expressed,
growth regulating, non-coding RNA that shares regulatory
elements with IGF2 [11]. The mechanism by which H19 interacts
with IGF2 and regulates growth is not fully understood and
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appears to involve long range interaction of differentially
methylated regions and complex loop structures that regulate
the activity of parental alleles [12,13,14]. More recently, H19 has
been identified as a trans regulator of an imprinted gene network
for growth and development [15], apparently through miRNAs
processed from the H19 transcript [11,16,17]. The H19 large
intergenic non-coding RNA (lincRNA) is highly expressed in
extra-embryonic cell lineages and is a developmental reservoir of
miR-675 that suppresses placental growth in the mouse [18]. The
IGF2 receptor (IGF2R) mediates endocytosis and clearance or
activation of a variety of ligands involved in the regulation of cell
growth and motility, including insulin-like growth factor II
[19,20,21].
Studies in mice have demonstrated that altered imprinting of
H19, IGF2 and IGF2R are associated with placental and fetal
growth abnormalities [11,22,23], some of which are consistent
with data from human studies. For example, (epi)mutations in the
H19-IGF2 region are associated with Silver-Russell and Beckwith-
Wiedemann syndromes, which manifest in utero in severely growth-
restricted and overgrowth phenotypes, respectively [24]. Further-
more, altered epigenetic regulation of the H19-IGF2 region in
human placenta has been associated with pregnancy complications
such as preeclampsia, which are preceded by placental pathologies
[25,26]. A significant role in placental development has been
established for H19 and IGF2 in mouse and human, but
knowledge on the role of IGF2R in human placental development
is limited. The IGF2R gene is imprinted in all tissues except brain
in mouse, but the majority of human samples indicate non-
imprinted biallelic expression [3,27,28,29]. The minority of
samples with imprinted or partially imprinted expression suggested
developmental stage-specific transient imprinting. However, the
developmental role of rare, transient or partial IGF2R imprinting
in the human placenta [3,27,30,31,32,33] remains to be estab-
lished.
In the human placenta, biallelic expression of imprinted genes,
including H19, has been observed at higher rates during the first
trimester of pregnancy compared to term [25,34,35]. Intriguingly,
biallelic expression of H19 in term placentae has been associated
with preeclampsia in one study [25], yet subtle variation in H19
allelic expression in healthy term placentae has also been observed
[36]. This limited research on allele-specific expression in the
human placenta suggested that imprinting may be dynamic across
gestation with potential plasticity in imprinting beyond blastocyst
and implantation stages. Although some differences in allele-
specific expression of imprinted genes between the first trimester
and term human placenta have been reported [34], there appear
to be no studies addressing potential changes across the first
trimester, a highly dynamic period of placental growth and
differentiation. Thus, there is little or no data on temporal
variation in imprinting of these genes across gestation, or if
imprinting is stable throughout the first trimester and later
gestation. In the present study, we quantified the allelic expression
ratio for H19, IGF2 and IGF2R and DNA methylation in the H19-
IGF2 imprinting control region across 6–12 weeks of gestation in




Ethics approval was granted by the Children, Youth and
Women’s Health Service Research Ethics Committee (REC2249/
2/13), the Central Northern Adelaide Health Service Ethics of
Human Research Committee (Approval #2005082) and the
University of Adelaide Human Research Ethics Committee (H-
137-2006). Written informed consent was obtained from all
patients.
Sample Collection
First trimester placental samples ranging from 6–12 weeks of
gestation were obtained from elective terminations of pregnancies
at the Women’s and Children’s Hospital, South Australia. The
consulting physician determined gestational age by observation
and the date of the last menstrual period. Placental villous samples
were washed in sterile PBS and snap frozen in liquid nitrogen
before being stored at 280uC. Term placenta samples were
collected from pregnancies classified as being uncomplicated by
using the criteria described in [37], and were collected and
dissected post-delivery at the Lyell McEwin Health Service, South
Australia, and incubated in RNAlater solution (Invitrogen) at 4uC
for 24 hours before being stored at 280uC.
Genotyping
DNA was extracted from placental tissue and parental blood
using the QiagenH DNeasyH blood and tissue kit following the
manufacturer’s instructions. DNA concentration was determined
using the NanoDropH ND-1000 Spectrophotometer and diluted to
12.5 ng/mL with nuclease-free water (Mo Bio Laboratories).
Isolated DNA from first trimester placental samples was genotyped
for IGF2 rs680, IGF2R rs998075 and IGF2R rs1570070 single
nucleotide polymorphisms (SNPs) by PCR and High Resolution
Melt (HRM) analysis (see Methods S1). Term placenta and
parental DNA SNP genotypes for H19 rs217727 and IGF2 rs680
were determined by multiplex PCR and the SequenomH
MassARRAYH system, using the iPLEXH GOLD single base
extension reaction on custom arrays at the Australian Genome
Research Facility, Brisbane, Australia.
Quantification of Allele Specific Expression
Placental samples were thawed and homogenised with 1 mL
TRIzol (Invitrogen) per 100 mg tissue. TRIzol (Invitrogen)
extraction was performed according to the manufacturer’s
guidelines. RNase-free glycogen (Ambion) was added at 25 mg
per 1 mL of TRIzol (Invitrogen) to aid in RNA visualisation. RNA
samples were DNase treated using the TURBO DNA-freeTM kit
(Ambion) following the manufacturer’s instructions for rigorous
treatment. Following DNase treatment, 2 mL of RNA was
subjected to PCR with DNA-specific primers (Table S1). The
DNase treatment was determined to be effective if samples showed
no amplification after 35 cycles. The concentration of DNase-
treated RNA was calculated with the NanoDropH ND-1000
Spectrophotometer.
First-strand cDNAs were synthesised from 500 ng DNase-
treated RNA using the iScriptTM cDNA Synthesis Kit (Bio-Rad),
following the manufacturer’s instructions. Reverse transcriptase
was omitted for negative controls and aliquots of the master mix
without added RNA were included in PCR experiments to rule
out contamination. Following reverse transcription, cDNA was
diluted 1:10 with nuclease-free water (Mo Bio Laboratories).
Aliquots from five cDNA samples were pooled and serially diluted
5-fold for primer validation and PCR optimisation.
PCR primers flanking SNP regions and pyrosequencing primers
were designed using the PSQTM assay design software (Biota-
geTM). Reverse primers featured 59 biotin modifications and were
HPLC purified. All oligonucleotides were synthesised by Gene-
Works (Adelaide) and are listed in Table S2. Each sample was
pyrosequenced in triplicate, with each replicate generated in an
independent PCR cycling run. PCR was performed using 10 mL
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reactions with 2 mL of cDNA, 5 mL SsoFast EvaGreen Supermix
(Bio-Rad) and 300 nM of each primer. Cycling conditions were
2 min enzyme activation at 95uC followed by 40 cycles of 5 sec at
95uC and 20 sec at 60uC. PCR products were sequenced by
pyrosequencing using the methods detailed below.
Quantification of DNA Methylation
DNA for methylation analysis was extracted from placental
villous tissue by homogenizing 50–100 mg tissue in 500 ml of TES
(10 mM Tris-HCL pH8.0, 1 mM EDTA, 100 mM NaCl), then
adding 300 mg Proteinase K and 30 ml of 20% SDS followed by an
overnight incubation at 37uC. Then 3 M NaCl was added to
precipitate proteins and the supernatant was collected by
centrifugation. The DNA was pelleted using 2 volumes of absolute
ethanol and washed in 70% ethanol, air dried and resuspended in
TE pH 8.0 [38].
Each DNA sample was bisulfite treated in triplicate by
EpigenDx (Massachusetts, USA) using 500 ng of DNA and a
proprietary bisulfite salt solution followed by incubation for 14
hours at 50uC. Bisulfite treated DNA was purified using Zymogen
DNA columns and was eluted with 20 ml of TE pH 8.0, 1 ml of
which was used for PCR reactions. The PCR was performed with
0.2 mM of each primer for EpigenDx methylation assays ADS025,
ADS596FS and ADS004 with one of the PCR primers being
biotinylated for purifying the final PCR product.
Pyrosequencing
The biotinylated PCR products were bound to Streptavidin
Sepharose HP (Amersham Biosciences, Sweden), and the Sephar-
ose beads containing the immobilized PCR product were purified,
washed and denatured using a 0.2 M NaOH solution and
rewashed all using the Pyrosequencing Vacuum Prep Tool
(Qiagen) as recommended by the manufacturer. Then 0.2 mM
pyrosequencing primer was annealed to the purified single-
stranded PCR product. 10 ml of the PCR products were
sequenced using the PSQ96 HS System (Biotage AB) following
the manufacturer’s instructions at EpigenDX Genome and
Epigenome Research Facility (Massachusetts, USA). The status
of each locus was analyzed individually using QCpG software
(Qiagen).
Statistical Analysis
Repressed allele expression differences between gestational age
classes for each gene were analyzed using one-way analysis of
variance (ANOVA). Differences between first trimester (6–12
weeks of gestation) and term (37–42 weeks of gestation) samples
were analyzed using the t-test. Differences in allelic expression
measured at two loci in the one sample were analyzed using the
paired t-test. The relationship between repressed allele expression
from two genes in the same sample was tested by calculating the
Pearson’s bivariate correlation coefficient. Differences in levels of
DNA methylation between first trimester and term samples were
tested for each individual CpG site and for each region using
independent t-tests. The relationship between repressed allele
expression and mean DNA methylation for each region and CpG
site was tested using Pearson’s correlation. Results were considered
significant at P,0.05. All statistical analyses were performed using
GraphPad PRISM 5.0.
Results
Quantification of Allele-specific Gene Expression in the
Human Placenta
DNA samples from placental tissue was genotyped for SNPs
H19 rs217727, IGF2 rs680, IGF2R rs998075 and IGF2R
rs1970070 to identify heterozygous individuals. Sixty-nine
samples in total were heterozygous for at least one of the
tested candidate SNPs. The number of heterozygotes identified
for each gestational age class is summarized in Table 1. As
parental DNA corresponding to term placenta samples was
available for 28 cases, we genotyped maternal and paternal
DNA for H19 and IGF2 polymorphisms to determine the
parental origin of expressed alleles. In all cases with sufficient
parental genotype information, H19 was maternally expressed
(n= 11) and IGF2 (n = 9) was paternally expressed, as expected
(Table S3).
Relative expression from each H19, IGF2 and IGF2R allele was
quantified in placenta samples by pyrosequencing of SNP loci.
Relative allelic expression levels for H19, IGF2 and IGF2R in first
trimester and term placenta samples are presented in Figures 1
and 2 with each gene showing a unique allele expression profile.
Technical replicates obtained from independent PCR reactions
showed average standard deviations (SD) of 0.44% for H19
rs217727, 1.02% for IGF2 rs680, 3.14% for IGF2R rs998075 and
3.84% for IGF2R rs1570070, respectively, indicating robust assays
with negligible inter-PCR variation. The greater standard
deviation for IGF2R replicates is likely due to the higher PCR
quantification cycle (Cq) required for data acquisition as compared
with H19 and IGF2 (data not shown). The ratio of repressed allele
to predominantly expressed allele is depicted in Figure 3, where a
0:100 ratio represents no expression from the repressed allele and
a 50:50 ratio represents balanced, i.e., bialleleic, non-imprinted
expression. Across first trimester gestational age classes, expression
from the H19 repressed allele shows notable inter-individual
variation in contrast to the almost uniform monoallelic expression
observed for IGF2 (Figure 3). IGF2R allele-specific expression in
first trimester placenta samples showed balanced expression, with
some samples potentially showing a slight allelic bias (Figures 2, 3).
Table 1. Number of informative heterozygous samples for
H19, IGF2 and IGF2R for each gestational age class.
Number of Heterozygotes
Gestational Age (weeks) H19 IGF2 IGF2R
6 1 1 1
7–8 6 5 14
9–10 4 6 8
11–12 2 2 1
37 1 0 NA
38 0 0 NA
39 7 5 NA
40 5 8 NA
41 5 6 NA
42 0 1 NA
Total 31 34 24
First trimester samples range from 6–12 weeks, term samples range from 37–42
weeks.
doi:10.1371/journal.pone.0051210.t001
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Biallelic Expression of IGF2R in the First Trimester
Placenta
Allelic expression ratios for IGF2R in first trimester placenta
was measured at two SNP loci (rs998075 n= 16 and rs1570070
n=13). Five samples were heterozygous for both SNPs, and no
significant difference (paired t-test, P=0.42) was detected
between the expression ratios for the two SNP loci, indicating
that both polymorphisms were equivalent in quantifying allele-
specific expression (Figure 2C). All heterozygous IGF2R samples
were therefore combined for analyses, and, when expression was
quantified at both loci in one sample, the average allelic ratio of
the two loci was used. The results clearly show biallelic IGF2R
expression in all first trimester placental samples assessed
(Figures 2A, B), with a mean allele expression ratio of 49:51
at both SNP loci (rs998075 SD=7.1%, rs1570070 SD=6.9%)
with expression ratios ranging from 36:64 to 49:51 (Figure 3).
These SNP based IGF2R pyrosequencing results provide no
evidence for IGF2R imprinted expression in the first trimester
placenta and thus confirm the non-imprinted status of IGF2R
throughout gestation.
Increased Expression from the H19 Repressed Allele is
Higher in First Trimester Placenta
Expression from the H19 repressed allele was quantified in 13
first trimester placenta samples obtained at 6–12 weeks of
gestation (Figure 1A). Mean expression from the repressed allele
was 13.5% (SD68.2; Figure 1A) and ranged from 0.9–24.7%
(Figure 3). Expression of the H19 repressed allele appeared to
decrease with gestational age in the first trimester samples
(Figure 4A), but we found no significant differences between first
trimester gestational age classes. To further test the hypothesis
that expression from the repressed H19 allele decreases across
gestation, we then quantified allelic expression in term placenta
samples obtained between 37–42 weeks of gestation (n= 18).
Expression from the repressed H19 allele at term was
significantly lower (P,0.001) than the level of expression
Figure 1. Relative expression from H19 and IGF2 alleles in the human placenta. Shaded bars for (A) H19 and (B) IGF2 represent the
proportion of expression (%) from each allele. Samples 1–38 are from first trimester (6–12 weeks of gestation) placentae and samples 39–69 are from
term (37–42 weeks of gestation) placentae.
doi:10.1371/journal.pone.0051210.g001
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observed in first trimester placenta samples (Figure 4B and
Table 2).
Expression from the IGF2 repressed allele contributed on
average 2.7% (SD 2.1%, n= 34) to total IGF2 transcript in
placenta samples (Figure 1B). No significant differences in
expression from the IGF2 repressed allele were observed between
first trimester gestational age classes (ANOVA P.0.05) or between
first trimester and term (Table 2, Figures 4C, D) placentae. These
results show that imprinted IGF2 expression is tightly regulated
and stable across gestation.
Eleven placenta samples were heterozygous for both H19 and
IGF2 polymorphisms, which allowed us to test for a correlation in
repressed allele expression for these adjacent co-regulated
imprinted genes. We found that expression from the H19
repressed allele was not correlated (P=0.88, r = 0.54) with
expression from the IGF2 repressed allele (Figure 5).
Locus-specific DNA Methylation Differences in the H19-
IGF2 Region between First Trimester and Term Placentae
To investigate if DNA methylation levels at specific CpG’s are
correlated with H19 repressed allele expression, we quantified
methylation levels in three regions (Figure 6) using bisulfite
pyrosequencing. The two regions upstream of the transcription
start site (TSS) (regions 1 and 2 on Figure 6) were selected as they
cover or are directly adjacent to sites that have been shown to be
differentially methylated [39], and region 3 (Figure 6) was selected
as it spanned the H19 promoter region and the TSS.
The first region (denoted 1 in Figure 6) encompassed five CpG
sites with a mean methylation level of 54.767.8%, which would be
Figure 2. Relative expression from IGF2R alleles in the human placenta. Shaded bars for (A) IGF2R rs1570070 and (B) IGF2R rs998075
represent the proportion of expression (%) in first trimester placentae. (C) Allelic expression ratios for IGF2R measured two SNP loci in the same
sample. These paired samples indicate both SNP loci are equivalent (paired t-test, P= 0.42) for evaluating IGF2R allele-specific expression.
doi:10.1371/journal.pone.0051210.g002
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expected at a differentially methylated imprinted locus. In region
1, there was no significant difference in mean methylation levels
between first trimester (54.866.9%) and term (53.567.2%)
placentae or at any of the 5 individual CpG sites (Figure 6, Table
S4). The second region assessed (denoted 2 in Figure 6), covered
12 CpG sites which showed overall hypomethylation, with a mean
methylation level of 30.963.9% in first trimester and 28.965.3%
in term placentae. When analyzed independently, 4 of the
12 CpG sites, 3 of which are adjacent to each other, showed
significantly higher methylation in first trimester placentae in
comparison to term placentae (Figure 6). The third region that
spanned the H19 TSS showed mean methylation levels of
16.163.1% in first trimester placentae and 15.563.5% in term
placentae. When each CpG site was analyzed individually, the
cytosine nucleotide 39 bp upstream from the H19 TSS (Figure 6)
showed significantly higher methylation (P=0.02) in first trimester
placentae (15.263.6% vs 12.063.2%). Details of DNA methyla-
tion levels in first trimester and term placentae at each individual
CpG site and the statistical comparisons between the groups are
listed in Table S4.
H19 Repressed Allele Expression is Correlated with
Higher Levels of DNA Methylation
As distinct variation in expression from the H19 repressed allele
in first trimester placentae was observed, we tested for correlations
between the level of repressed allele expression and levels of DNA
methylation at CpG’s of first trimester placentae. In region 1, a
significant positive correlation (P,0.001, r = 0.65) was observed
between repressed allele expression and the mean methylation
level across the region (Figure 7A). When each of the 5 CpG sites
in this region were analyzed independently for the same
correlation, the results remained significant for each site (Table
S5). This correlation was not observed for region 2 (Figure 7B,
P=0.36, r = 0.07) or 3 (Figure 7C, P=0.47, r = 0.05) or for any
individual CpG sites within these regions (Table S5).
Discussion
Imprinted genes are known to be critically involved in placental
development and function. Aberrant patterns of imprinted gene
expression are implicated in pregnancy complications such as
preeclampsia and intrauterine growth restriction [5,40,41,42,43].
Although the symptoms of these conditions manifest late in
pregnancy, their pathogenesis is commonly attributed to compro-
mised first trimester placental development [44]. Previous research
on genomic imprinting in the human placenta has focused on the
term placenta [25,32,36,41,45,46] and data during the first
trimester of gestation is limited [27,34,35,47]. In the present
study, we investigated the imprinting status (i.e., allele-specific
expression) of three genes, H19, IGF2 and IGF2R, which have
known, but poorly understood, associations with pregnancy
complications and placental abnormalities in humans and/or
animal models [6,7,8,9,10]. We assessed allele-specific expression
of these genes and DNA methylation in the H19-IGF2 imprinting
control region in first trimester (6–12 weeks of gestation) and term
(37–42 weeks of gestation) placentae.
We assessed IGF2R allele-specific expression, as the imprinting
status of this important gene for prenatal growth and development
remains controversial in human. We observed balanced expression
from both IGF2R alleles, and although we did not investigate any
potential imprinting mechanisms for this gene, these results suggest
IGF2R is not imprinted in the first trimester placenta. Imprinting
of IGF2R has been suggested to be a polymorphic trait in humans,
with a small proportion of individuals showing monoallelic
expression or partial imprinting [3,27,33]. In this study, we
assessed more informative samples than previous studies
[3,27,33,48] but found no evidence for polymorphic IGF2R
imprinting in the placenta. Although we observed overall a
balanced expression of alleles for IGF2R, individual allelic
expression ratios ranged from 36:64 to 49:51. This variation
may reflect what has been described previously as partial
repression or allelic preference [27,33]. It is presently unclear if
this subtle imbalance of IGF2R allelic expression is due to genetic
Figure 3. Allelic expression ratios for H19, IGF2 and IGF2R in the human placenta. The 50:50 ratio represents equal expression from both
alleles and 0:100 ratio represents expression exclusively from one allele. Each point on the graph represents the allelic expression ratio measured in
an individual placental sample. H19 and IGF2 samples are from first trimester and term placentae, IGF2R samples are all from first trimester placentae.
doi:10.1371/journal.pone.0051210.g003
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variation in allele-specific epigenetic regulation or a parent-of-
origin effect.
Allele-specific expression of H19 showed considerable inter-
individual variation, with expression from the repressed (i.e.
imprinted) allele contributing up to 25% of total H19 transcript
Figure 4. Ratio of expression from each allele in human first trimester and term placentae measured by pyrosequencing. Each point
on the graph represents the allelic expression ratio observed in an individual placental sample. (A) H19 allelic expression ratio for each gestational
age class. (B) Expression from the H19 repressed allele is significantly higher (*P,0.001) in first trimester placental samples. (C-D) IGF2 allelic
expression ratios are similar for each gestational age class (C) with no significant difference (D) between first trimester and term. First trimester
samples are 6–12 weeks of gestation term samples are 37–42 weeks of gestation.
doi:10.1371/journal.pone.0051210.g004
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in the first trimester placenta. In contrast, IGF2 showed
predominantly monoallelic expression and little variation
between individuals, with one allele contributing more than
90% of IGF2 transcript in all investigated samples. This
indicated that IGF2 allele-specific expression is tightly regulated
in the first trimester placenta and suggests that IGF2 imprinting
is established early in development and remains stable
throughout gestation.
Determining loss of imprinting or biallelic expression of
imprinted genes was previously performed by restriction fragment
length polymorphism (RFLP) analysis. This method provides a
qualitative or semi-quantitative assessment of monoallelic or
biallelic expression. In human placentae from uncomplicated
pregnancies, H19 RFLP data showed biallelic expression before 10
weeks of gestation and imprinted expression at term [25,35].
However, term placentae from preeclamptic pregnancies were
reported to display biallelic expression with the RFLP method
[25]. This biallelic H19 expression could indicate a failure to
establish correct H19 imprinting with downstream effects on
placental development [25,35]. The data presented in the current
study show that H19 expression from the imprinted, i.e. repressed,
allele can range from 9–22% at 9–10 weeks of gestation,
highlighting the potential ambiguity in classifying expression as
mono- or biallelic by less sensitive methods. Our data support the
view [32,49] that classification of genes as imprinted or non-
imprinted by qualitative methods may be a less meaningful
distinction than quantitative measurements of imprinting status
based on precise estimates of relative contributions from each
allele.
More recently, quantitative PCR and pyrosequencing have
been used to evaluate allele-specific expression in placental tissue.
By using these highly sensitive methodologies, expression from the
‘‘silenced’’, imprinted, alleles has been generally higher in first
trimester placentae [46] with some variation at term [36]. Both the
RFLP assay and quantitative allele-specific expression approaches
support the concept that repressed allele expression changes
through gestation in the placenta, particularly during early
pregnancy [25,34,35,46]. Using placental tissue from 6–12 weeks
of gestation, we tested the hypothesis that imprinted allele-specific
expression changes during the first trimester of pregnancy. We
found no significant differences between early and late first
trimester allelic expression ratios for H19, IGF2 or IGF2R.
Although we quantified allelic expression ratios using a highly
sensitive technique, the method used for classifying gestational age,
our sample size, and the proportion of heterozygotes in each group
may have prevented the detection of significant changes across first
trimester age groups. When comparing first trimester and term
placenta samples for H19, we found a significant decrease in the
proportion of repressed allele expression at term. Furthermore,
these results for H19 show notable inter-individual variation early
during placental development, and more uniformity in allelic
expression ratios as gestation progresses. This is a clear demon-
stration of dynamic change in imprinting status well beyond the
blastocyst and implantation stages. However, an alternative
explanation for the observed differences in H19 allelic expression
ratios between first trimester and term samples in the present study
could be the unbiased sampling of material from elective
terminations of pregnancy versus the selected material at term
that came from normal pregnancies only. Placental tissue from
elective terminations of pregnancy in first trimester will, by
necessity, include those from pregnancies that may have been
destined to develop a pregnancy complication e.g. preeclampsia,
preterm labour or intrauterine growth restriction which are
typically diagnosed later in gestation. Potentially, first trimester
placental samples exhibiting expression from the repressed allele
may have been destined to retain biallelic expression and associate
with preeclampsia later. However, we consider this unlikely given
that 8 out of 13 first trimester samples had greater than 10%
expression from the repressed allele and preeclampsia occurs in
just 8% of women in the community where our samples were
collected [50].
Our results show H19 expression from the repressed allele is not
correlated with expression from the IGF2 repressed allele in the
same samples. The prevailing regulatory model of the H19-IGF2
region based on differential DNA methylation predicts that both
genes are not expressed from a single chromosome. Although this
model is supported by considerable evidence [12,51,52] (and
references cited therein), there is also evidence to suggest that this
model may be insufficient (reviewed in [53]). The data presented
here show higher expression from the repressed H19 allele is not
correlated with any change in IGF2 repressed allele expression in
individual placentae. Additionally, we show that DNA methylation
levels at CpG sites (1946–2005 bp upstream of the H19 TSS) that
flank the 6th CTCF binding domain [39], are positively correlated
with the level of expression from the H19 repressed allele, which
Table 2. Relative levels of repressed allele expression in
human first trimester and term placentae.
% Repressed allele expression
First trimester Term P value
H19 13.568.3 3.462.0 ,0.0001
IGF2 2.662.0 1.961.1 0.1734
IGF2R 43.863.2 ND –
ND=Not Determined.
doi:10.1371/journal.pone.0051210.t002
Figure 5. Relative level of expression from repressed alleles in
samples heterozygous for both H19 rs217727 and IGF2 rs680.
Graph shows increased expression from the H19 repressed allele is not
correlated (P= 0.09, r = 0.54) with expression from the IGF2 repressed
allele.
doi:10.1371/journal.pone.0051210.g005
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was unexpected given the prevailing regulatory model. Further-
more, we observed significantly higher DNA methylation in first
trimester placentae in the region 422–524 bp upstream of the H19
TSS that surrounds the differentially methylated region (DMR)
[39], despite finding no correlation with H19 repressed allele
expression. This suggests DNA methylation in the DMR decreases
Figure 6. Placental methylation levels in regions upstream and covering the H19 transcription start site (TSS). Each genomic region
where DNA methylation was measured is highlighted in yellow and numbered 1–3. DNA methylation levels for individual CpG loci are shown for first
trimester (red circles, n = 13) and term (blue circles, n = 18) placentae. Distance (bp) of cytosine nucleotide from H19 TSS is represented on x-axis. Each
data point represents the mean methylation level for the gestational age class. * Indicates a significant difference in methylation levels between first
trimester and term placentae at individual CpG sites. Error bars represent SEM and when not present SEM was too low to depict on the graph. The
schematic representation below the graph highlights the regions between H19 and IGF2 where bisulfite DNA pyrosequencing was performed. Region
1 covers 5 CpG sites (Chr11:2021011–2021070), region 2 covers 12 CpG sites (Chr11:2021011–2021070) and region 3 covers 5 CpG sites
(Chr11:2019079–2019145). Genomic coordinates refer to reference assembly GRCh37/hg19.
doi:10.1371/journal.pone.0051210.g006
Figure 7. Levels of H19 repressed allele expression and DNA methylation in human first trimester placentae. (A) Increased expression
from the repressed H19 allele is positively correlated (P= 0.0016, r = 0.61) with increased DNA methylation in region 1. (B & C) H19 repressed allele
expression is not correlated with DNA methylation in region 2 (P= 0.3626, r = 0.08) or region 3 (P=0.4791, r = 0.04). Each point on the graph
represents individual first trimester placenta samples. Methylation levels in each region represent the average methylation from 5 CpG sites in region
1 (Chr11:2021011–2021070), 12 CpG sites in region 2 (Chr11:2021011–2021070) and 5 CpG sites in region 3 (Chr11:2019079–2019145). Genomic
coordinates refer to reference assembly GRCh37/hg19.
doi:10.1371/journal.pone.0051210.g007
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progressively throughout gestation with no effect on H19 allelic
regulation. Together, these findings suggest that the methylation
dependant enhancer competition model of the H19-IGF2 locus
may not fully explain the patterns of allele-specific expression
observed for these genes in the early human placenta, as suggested
previously [53]. However, although we assessed DNA methylation
at sites within the H19-IGF2 regulatory region, we did not assess
methylation across all the CTCF binding sites upstream of H19.
Moreover, we did not investigate additional regulatory mecha-
nisms, such as the actions of other non-coding RNA’s and
repressive histone modifications that are involved in placental-
specific imprinting [54,55,56,57]. Therefore we are unable to rule
out other mechanistic changes that may be influencing H19 allele
specific expression.
An important consideration when using placental tissue for
studying genomic imprinting is that this organ arises from multiple
extra-embryonic and embryonic cell lineages. Cells descended
from both the inner cell mass and trophectoderm may show major
epigenetic differences [58], and as a result, analysis of whole
placental villous tissue may not identify cell lineage-specific
imprinting effects. In this study, we show a clear imprinting effect
for IGF2 in all heterozygous first trimester placenta samples, which
suggests that all cell types composing the placental villi had IGF2
imprinting mechanisms in place. However, for H19 we observed
notable inter-individual variation in expression from the imprinted
allele. This variation could be due to the heterogeneous nature of
the placental villous tissue sampled and H19 lineage-specific
imprinting at the single cell level. Cell-specific imprinted gene
expression has been proposed as an all or none phenomenon in
placental cell lines [59], and H19 biallelic expression has been
shown to be specific to extravillous cytotrophoblast cells [47],
suggesting there is no intermediate imprinting effect at the single
cell level. Therefore, observing variations in relative expression
from the imprinted allele in placental tissue may simply reflect the
fraction of cells with complete biallelic expression [59]. As first
trimester placental tissue sampling is expected to yield a higher
proportion of extravillous cytotrophoblast cells than those
collected at term, changes in the level of imprinting across
gestation may reflect proportional changes in cell lineage
populations as the placenta differentiates. This suggests future
studies of placental imprinting dynamics should consider the
potential influence of placental cell type heterogeneity.
The H19, IGF2 and IGF2R genes have key roles in placental
development, yet the phenotypic effect of their allele-specific
expression across gestation remains unknown. However, the role
of H19 as a regulator of the recently described imprinted gene
network suggests potentially significant phenotypic effects [15].
This may depend on differences in gene dosage, but could also
involve more complex regulatory effects in trans. To date, the
normal developmental patterns of imprinted gene expression in
the human placenta are poorly understood. As altered patterns of
imprinting in term placentae are associated with pregnancy
complications, identifying when these abnormal patterns are
established may aid in elucidating the origins of placental
abnormalities implicated in their aetiology. Our results highlight
the requirement for robust and sensitive methods to determine the
role of imprinted allele-specific expression in placentae from
complicated pregnancies. Undoubtedly, precise methods and
comprehensive studies will be required to progress towards
understanding the molecular basis of potentially life threatening
pregnancy complications in which defective placentation is
implicated.
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